COPENHAGEN, Denmark, March 21, 2022 – Bavarian Nordic A/S (OMX: BAVA) (“the Company”) announced today, that it has entered into an exclusive license and supply agreement with Nuance Pharma, a Shanghai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback